Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2012

01-02-2012 | Original Article

Hypervolemic hypernatremia in patients recovering from acute kidney injury in the intensive care unit

Authors: Ramin Sam, Peter Hart, Roxanna Haghighat, Todd S. Ing

Published in: Clinical and Experimental Nephrology | Issue 1/2012

Login to get access

Abstract

Background

A high incidence of hypernatremia is often observed in patients recovering from acute kidney injury (AKI) in intensive care units.

Methods

An unselected cohort of 20 adult patients recovering from AKI in the intensive care unit of a single institution during a 1-year period, were investigated. Serum and urine electrolytes, osmolality, urea nitrogen and creatinine were measured in an attempt to determine the cause of the hypernatremia.

Results

Eighty-eight percent of patients who could not drink fluids were found to have hypernatremia (serum Na >145 mEq/L). Even though the hypernatremia was mild in most patients (146–160 mEq/L), the average rise in serum sodium concentration was 17.4 mEq/L. The average urine osmolality was 384 mmol/kg of which 47.6 and 32.8 mmol/kg were contributed by sodium and potassium, respectively. The patients had hypervolemia as evidenced by the presence of edema and an average weight gain of 21.5 kg at the onset of the hypernatremia. The rise in serum sodium level coincided with an increase in urine output.

Conclusion

The hypernatremia is believed to be due to post-AKI diuresis in the face of inability to maximally concentrate the urine because of renal failure. The diuresis caused a disproportionate loss of water in excess of that of sodium in the absence of replenishment of the water loss. Additionally, the patients were hypervolemic due to the retention of large quantities of sodium and water as a result of infusion of substantial volumes of physiological saline prior to the development of hypernatremia.
Literature
1.
go back to reference Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50:952–7.PubMedCrossRef Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50:952–7.PubMedCrossRef
2.
go back to reference Luetscher JA, Blakman SS. Severe kidney and brain injury following sulfathiazole. Ann Intern Med. 1943;15:741. Luetscher JA, Blakman SS. Severe kidney and brain injury following sulfathiazole. Ann Intern Med. 1943;15:741.
3.
go back to reference Brady HR, Brenner BM. Acute renal failure. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 1541–51. Brady HR, Brenner BM. Acute renal failure. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 1541–51.
4.
go back to reference Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 271–83. Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 271–83.
5.
go back to reference Berl T, Anderson RJ, McDonald KM, et al. Clinical disorders of water metabolism. Kidney Int. 1976;10:117–32.PubMedCrossRef Berl T, Anderson RJ, McDonald KM, et al. Clinical disorders of water metabolism. Kidney Int. 1976;10:117–32.PubMedCrossRef
6.
go back to reference Sedlacek M, Schoolwerth AC, Remillard BD. Electrolyte disturbances in the intensive care unit. Semin Dial. 2006;19:496–501.PubMedCrossRef Sedlacek M, Schoolwerth AC, Remillard BD. Electrolyte disturbances in the intensive care unit. Semin Dial. 2006;19:496–501.PubMedCrossRef
7.
go back to reference Marsden PA, Halperin ML. Pathophysicological approach to patients presenting with hypernatremia. Am J Nephrol. 1985;5:229–35.PubMedCrossRef Marsden PA, Halperin ML. Pathophysicological approach to patients presenting with hypernatremia. Am J Nephrol. 1985;5:229–35.PubMedCrossRef
9.
go back to reference Pham PCT, Pham PMT, Pham PTT. Vasopressing excess and hyponatremia. Am J Kidney Dis. 2006;47:727–37.PubMedCrossRef Pham PCT, Pham PMT, Pham PTT. Vasopressing excess and hyponatremia. Am J Kidney Dis. 2006;47:727–37.PubMedCrossRef
10.
go back to reference Takamata A, Yoshida T, Nishida N, Morimoto T. Relationship of osmotic inhibition in thermoregulatory responses and sweat sodium concentration in humans. Am J Physiol Regul Integr Comp Physiol. 2001;280:R623–9.PubMed Takamata A, Yoshida T, Nishida N, Morimoto T. Relationship of osmotic inhibition in thermoregulatory responses and sweat sodium concentration in humans. Am J Physiol Regul Integr Comp Physiol. 2001;280:R623–9.PubMed
11.
go back to reference Murphy MS, Sibal A, Mann JR. Persistent diarrhea and occult vipomas in children. BMJ. 2000;320:1524–6.PubMedCrossRef Murphy MS, Sibal A, Mann JR. Persistent diarrhea and occult vipomas in children. BMJ. 2000;320:1524–6.PubMedCrossRef
12.
go back to reference Ashraf N, Locksley R, Arieff A. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70:1163–8.PubMedCrossRef Ashraf N, Locksley R, Arieff A. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70:1163–8.PubMedCrossRef
13.
go back to reference Narins RG, Jones ER, Stom MC, Rudnick MR, Bastl CP. Diagnostic strategies in disorders of fluid, electrolyte and acid–base homeostasis. Am J Med. 1982;72:496–520.PubMedCrossRef Narins RG, Jones ER, Stom MC, Rudnick MR, Bastl CP. Diagnostic strategies in disorders of fluid, electrolyte and acid–base homeostasis. Am J Med. 1982;72:496–520.PubMedCrossRef
14.
go back to reference Wardener HE. The kidney—an outline of normal and abnormal structure and function. 3rd ed. Boston: Little, Brown and Co; 1967. p. 143–64. Wardener HE. The kidney—an outline of normal and abnormal structure and function. 3rd ed. Boston: Little, Brown and Co; 1967. p. 143–64.
15.
go back to reference Swartz R. Fluid, electrolyte, and acid–base changes during renal failure. In: Kokko JP, Tannen RL, editors. Fluid and electrolytes. 3rd ed. Philadelphia: WB Saunders Co; 1996. p. 487–532. Swartz R. Fluid, electrolyte, and acid–base changes during renal failure. In: Kokko JP, Tannen RL, editors. Fluid and electrolytes. 3rd ed. Philadelphia: WB Saunders Co; 1996. p. 487–532.
16.
go back to reference Maher JF, Schreiner GE, Water TJ. Osmotic diuresis due to retained urea after release of obstructive uropathy. N Engl J Med. 1963;268:1099–104.CrossRef Maher JF, Schreiner GE, Water TJ. Osmotic diuresis due to retained urea after release of obstructive uropathy. N Engl J Med. 1963;268:1099–104.CrossRef
18.
go back to reference D’Angelo A, Del Prete D. Urinary tract obstruction. In: Jorres A, Ronco C, Kellum JA, editors. Management of acute kidney problems. Berlin: Springer; 2010. p. 53–61.CrossRef D’Angelo A, Del Prete D. Urinary tract obstruction. In: Jorres A, Ronco C, Kellum JA, editors. Management of acute kidney problems. Berlin: Springer; 2010. p. 53–61.CrossRef
19.
go back to reference DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981;21:165–71.PubMedCrossRef DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981;21:165–71.PubMedCrossRef
20.
go back to reference Millionis HJ, Liamis G, Elisaf MS. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch Intern Med. 2000;160:1541–2. (letter).CrossRef Millionis HJ, Liamis G, Elisaf MS. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch Intern Med. 2000;160:1541–2. (letter).CrossRef
21.
go back to reference Kahn T. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch Intern Med. 2000;160:1542. (author’s reply). Kahn T. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch Intern Med. 2000;160:1542. (author’s reply).
22.
go back to reference Hoorn EJ, Betjes MGH, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transpl. 2008;23(5):1562–8.CrossRef Hoorn EJ, Betjes MGH, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transpl. 2008;23(5):1562–8.CrossRef
24.
go back to reference Sam R, Ing TS. Sodium and water disturbances. In: Lai KN, editor. A practical manual of renal medicine, nephrology, dialysis and transplantation. Singapore: World Scientific Publishing Co.; 2009. p. 45–79.CrossRef Sam R, Ing TS. Sodium and water disturbances. In: Lai KN, editor. A practical manual of renal medicine, nephrology, dialysis and transplantation. Singapore: World Scientific Publishing Co.; 2009. p. 45–79.CrossRef
Metadata
Title
Hypervolemic hypernatremia in patients recovering from acute kidney injury in the intensive care unit
Authors
Ramin Sam
Peter Hart
Roxanna Haghighat
Todd S. Ing
Publication date
01-02-2012
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2012
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0537-7

Other articles of this Issue 1/2012

Clinical and Experimental Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.